CCThe Chemours Company
What is the market doing?
No clear lean: insiders cluster-buying, but in a downtrend (−24% vs 200-day) and heavily shorted (+10% of shares).
In a downtrend, below its 50- and 200-day averages. Price is −24% vs its 200-day average.
Multiple insiders bought with their own money, the strongest form of the signal (the 90 days ending Oct 8, 2026).
Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CC is trading
The Chemours Company is −19% over the past year while the S&P 500 is +18%: 37 points behind the market. Through the fall, its own insiders bought $489K more stock than they sold.
1-year return · S&P 500 +18%
- vs 200-day average
- −24%
vs 200-day average · a clear downtrend
- RSI (14)
- 37
RSI (14) · neutral
- Below its 52-week high
- 51%
Below its 52-week high
Details›
- Last close2026-10-09
- $13.61
- 1 monthS&P 500 +2.7%
- −9.7%
- 1 yearS&P 500 +18%
- −19%
- 5 yearsS&P 500 +88%
- −48%
- vs 50-day average$15.06
- −9.6%
- 52-week high
- $27.84
- 52-week low
- $10.39
- Annualised volatility
- 64%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $489K
| Year | Return |
|---|---|
| 2026 (year to date) | +16% |
| 2025 | −28% |
| 2024 | −44% |
| 2023 | +6.5% |
| 2022 | −6.0% |
| 2021 | +40% |
| 2020 | +46% |
| 2019 | −33% |
| 2018 | −42% |
| 2017 | +127% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +8.4% |
| Feb | 10 | 4 of 10 | −2.6% |
| Mar | 10 | 6 of 10 | +3.9% |
| Apr | 10 | 6 of 10 | +5.9% |
| May | 10 | 4 of 10 | −2.4% |
| Jun | 10 | 4 of 10 | +2.7% |
| Jul | 11 | 8 of 11 | +3.7% |
| Aug | 11 | 5 of 11 | +2.0% |
| Sep | 11 | 6 of 11 | −3.8% |
| Oct | 11 | 5 of 11 | −2.1% |
| Nov | 10 | 6 of 10 | +9.7% |
| Dec | 10 | 4 of 10 | −0.12% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Specialty Chemicals
Ranks #24 of 33 by RyuScore